Substance use and mental health characteristics among pregnant individuals with medical and non-medical benzodiazepine use early in pregnancy
Our results suggest that research relying on prescription data alone and the medical system may be missing pregnant individuals using benzodiazepines. This points to a need for additional measures and screenings (e.g., urine toxicology tests) in both research and clinical settings. Our findings also underscore a need for additional services for pregnant individuals with both medical and non-medical benzodiazepine use.
Authors
- Brian T. Bateman (ORCID: https://orcid.org/0000-0001-5950-8683)
- Ayesha C. Sujan (ORCID: https://orcid.org/0000-0002-4374-9949)
- Natalie E. Slama (ORCID: https://orcid.org/0000-0002-4930-1061)
- Kelly C. Young‐Wolff (ORCID: https://orcid.org/0000-0002-6177-534X)
- Deborah Ansley (ORCID: https://orcid.org/0000-0002-7806-929X)
- Carley Castellanos
Institutions
- Kaiser Permanente (US)
- University of California, San Francisco (US)
- Stanford University (US)
Publication Details
- Journal
- Drug and Alcohol Dependence Reports
- Published
- 2025-05-16
- DOI
- https://doi.org/10.1016/j.dadr.2025.100345
- Primary Topic
- Maternal Mental Health During Pregnancy and Postpartum
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of General Medical Sciences